American Century Companies Inc. Has $6.88 Million Stake in USANA Health Sciences, Inc. $USNA

Key Points

• American Century Companies Inc. increased its stake in USANA Health Sciences by 9.2%, owning 255,242 shares valued at approximately $6.88 million as of the latest SEC filing.
• USANA reported Q2 earnings of $0.74 per share, surpassing the consensus estimate of $0.54, with total revenue reaching $235.85 million compared to expectations of $225.20 million.
• Analysts have recently upgraded USANA's stock rating from "hold" to "buy," with an average target price set at $36.00, indicating potential upside for investors.

American Century Companies Inc. raised its position in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 9.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 255,242 shares of the company's stock after purchasing an additional 21,445 shares during the quarter. American Century Companies Inc. owned about 1.37% of USANA Health Sciences worth $6,884,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. PNC Financial Services Group Inc. increased its stake in shares of USANA Health Sciences by 339.6% in the first quarter. PNC Financial Services Group Inc. now owns 998 shares of the company's stock valued at $27,000 after purchasing an additional 771 shares during the period. Versant Capital Management Inc boosted its holdings in shares of USANA Health Sciences by 542.5% in the first quarter. Versant Capital Management Inc now owns 1,150 shares of the company's stock valued at $31,000 after acquiring an additional 971 shares in the last quarter. Parallel Advisors LLC boosted its holdings in shares of USANA Health Sciences by 8,141.2% in the first quarter. Parallel Advisors LLC now owns 1,401 shares of the company's stock valued at $38,000 after acquiring an additional 1,384 shares in the last quarter. US Bancorp DE boosted its holdings in shares of USANA Health Sciences by 13.1% in the first quarter. US Bancorp DE now owns 4,611 shares of the company's stock valued at $124,000 after acquiring an additional 535 shares in the last quarter. Finally, Public Employees Retirement System of Ohio boosted its holdings in shares of USANA Health Sciences by 635.5% in the fourth quarter. Public Employees Retirement System of Ohio now owns 5,075 shares of the company's stock valued at $182,000 after acquiring an additional 4,385 shares in the last quarter. Institutional investors and hedge funds own 54.25% of the company's stock.

Insider Buying and Selling

In related news, Director Gilbert A. Fuller sold 1,058 shares of the firm's stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $29.10, for a total transaction of $30,787.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider David Mulham Mulham sold 3,515 shares of the firm's stock in a transaction that occurred on Wednesday, July 30th. The stock was sold at an average price of $30.26, for a total transaction of $106,363.90. Following the sale, the insider owned 9,260 shares of the company's stock, valued at $280,207.60. The trade was a 27.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 5,073 shares of company stock valued at $151,982 over the last 90 days. 0.63% of the stock is currently owned by insiders.

USANA Health Sciences Stock Down 0.6%

NYSE:USNA traded down $0.19 during trading hours on Tuesday, reaching $31.72. 109,692 shares of the company's stock were exchanged, compared to its average volume of 93,255. The company has a market capitalization of $579.52 million, a P/E ratio of 17.62, a price-to-earnings-growth ratio of 1.01 and a beta of 0.64. USANA Health Sciences, Inc. has a 12 month low of $23.10 and a 12 month high of $41.83. The business's 50-day simple moving average is $31.19 and its two-hundred day simple moving average is $29.58.

USANA Health Sciences (NYSE:USNA - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The company reported $0.74 earnings per share for the quarter, topping analysts' consensus estimates of $0.54 by $0.20. The firm had revenue of $235.85 million during the quarter, compared to analysts' expectations of $225.20 million. USANA Health Sciences had a net margin of 3.79% and a return on equity of 9.48%. USANA Health Sciences has set its FY 2025 guidance at 2.350-3.000 EPS. As a group, sell-side analysts anticipate that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded shares of USANA Health Sciences from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $36.00.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.